{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:30:52Z","timestamp":1787776252060,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41417-026-01064-1","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:29:47Z","timestamp":1785155387000},"page":"1041-1052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CLK3 regulates tumor angiogenesis by modulating HIF1\u03b1 ubiquitination"],"prefix":"10.1038","volume":"33","author":[{"given":"Jing","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7543-9055","authenticated-orcid":false,"given":"Xuling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1064_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00401-012-1066-5","volume":"124","author":"KH Plate","year":"2012","unstructured":"Plate KH, Scholz A, Dumont DJ. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol. 2012;124:763\u201375.","journal-title":"Acta Neuropathol"},{"key":"1064_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188352","volume":"1873","author":"JJ Serrano","year":"2020","unstructured":"Serrano JJ, Delgado B, Medina MA. Control of tumor angiogenesis and metastasis through modulation of cell redox state. Biochim Biophys Acta Rev Cancer. 2020;1873:188352.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1064_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0766-4","volume":"17","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang L, Chen C, Chu X. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer. 2018;17:22.","journal-title":"Mol Cancer"},{"key":"1064_CR4","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.1158\/0008-5472.CAN-12-2773","volume":"72","author":"AC Hielscher","year":"2012","unstructured":"Hielscher AC, Gerecht S. Engineering approaches for investigating tumor angiogenesis: exploiting the role of the extracellular matrix. Cancer Res. 2012;72:6089\u201396.","journal-title":"Cancer Res"},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends Immunol. 2016;37:208\u201320.","journal-title":"Trends Immunol"},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77:1745\u201370.","journal-title":"Cell Mol Life Sci"},{"key":"1064_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larrivee B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20:409\u201326.","journal-title":"Angiogenesis"},{"key":"1064_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2021.06.005","volume":"567","author":"RP Virgirinia","year":"2021","unstructured":"Virgirinia RP, Nakamura M, Takebayashi-Suzuki K, Fatchiyah F, Suzuki A. The dual-specificity protein kinase Clk3 is essential for Xenopus neural development. Biochem Biophys Res Commun. 2021;567:99\u2013105.","journal-title":"Biochem Biophys Res Commun"},{"key":"1064_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/excr.1998.4083","volume":"241","author":"PI Duncan","year":"1998","unstructured":"Duncan PI, Stojdl DF, Marius RM, Scheit KH, Bell JC. The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing. Exp Cell Res. 1998;241:300\u20138.","journal-title":"Exp Cell Res"},{"key":"1064_CR10","doi-asserted-by":"crossref","unstructured":"Zhou Q, Lin M, Feng X, Ma F, Zhu Y, Liu X, et al. Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. J Exp Med. 2020;217:e20191779.","DOI":"10.1084\/jem.20191779"},{"key":"1064_CR11","doi-asserted-by":"publisher","first-page":"9201","DOI":"10.2147\/OTT.S224527","volume":"12","author":"H Li","year":"2019","unstructured":"Li H, Cui X, Hu Q, Chen X, Zhou P. CLK3 is a direct target of miR-144 and contributes to aggressive progression in hepatocellular carcinoma. Onco Targets Ther. 2019;12:9201\u201313.","journal-title":"Onco Targets Ther"},{"key":"1064_CR12","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.1002\/cam4.5561","volume":"12","author":"M Xue","year":"2023","unstructured":"Xue M, Mi S, Zhang Z, Wang H, Chen W, Wei W, et al. MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3. Cancer Med. 2023;12:8403\u201314.","journal-title":"Cancer Med"},{"key":"1064_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114132","volume":"440","author":"Y Ma","year":"2024","unstructured":"Ma Y, Gao F, Liu Y. CLK3 positively promoted colorectal cancer proliferation by activating IL-6\/STAT3 signaling. Exp Cell Res. 2024;440:114132.","journal-title":"Exp Cell Res"},{"key":"1064_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-024-00132-y","volume":"19","author":"J Shen","year":"2024","unstructured":"Shen J, Zhao Y, Man Y, Sun X. CLK3 promotes tumor proliferation by activating MYC signaling. Cell Div. 2024;19:28.","journal-title":"Cell Div"},{"key":"1064_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000539642","volume":"33","author":"Y Pan","year":"2024","unstructured":"Pan Y, Yang X, Chen M, Shi K, Lyu Y, Meeson AP, et al. Role of cancer side population stem cells in ovarian cancer angiogenesis. Med Princ Pr. 2024;33:403\u201313.","journal-title":"Med Princ Pr"},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther. 2022;7:113.","journal-title":"Signal Transduct Target Ther"},{"key":"1064_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016;17:611\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1064_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1064_CR19","doi-asserted-by":"crossref","unstructured":"Mabeta P, Steenkamp V. The VEGF\/VEGFR axis revisited: implications for cancer therapy. Int J Mol Sci. 2022;23:15585.","DOI":"10.3390\/ijms232415585"},{"key":"1064_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W. HIF-1alpha pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015;5:378\u201389.","journal-title":"Acta Pharm Sin B"},{"key":"1064_CR21","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1172\/JCI137552","volume":"130","author":"EC de Heer","year":"2020","unstructured":"de Heer EC, Jalving M, Harris AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130:5074\u201387.","journal-title":"J Clin Invest"},{"key":"1064_CR22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/med.21771","volume":"41","author":"L You","year":"2021","unstructured":"You L, Wu W, Wang X, Fang L, Adam V, Nepovimova E, et al. The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev. 2021;41:1622\u201343.","journal-title":"Med Res Rev"},{"key":"1064_CR23","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","volume":"8","author":"GL Semenza","year":"2002","unstructured":"Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8:S62\u20137.","journal-title":"Trends Mol Med"},{"key":"1064_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.devcel.2009.01.003","volume":"16","author":"P Fraisl","year":"2009","unstructured":"Fraisl P, Mazzone M, Schmidt T, Carmeliet P. Regulation of angiogenesis by oxygen and metabolism. Dev Cell. 2009;16:167\u201379.","journal-title":"Dev Cell"},{"key":"1064_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvq045","volume":"86","author":"S Rey","year":"2010","unstructured":"Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 2010;86:236\u201342.","journal-title":"Cardiovasc Res"},{"key":"1064_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","volume":"12","author":"B Keith","year":"2011","unstructured":"Keith B, Johnson RS, Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011;12:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"1064_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.apsb.2020.09.007","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Shao X, Cao J, Zhu H, Yang B, He Q, et al. Phosphorylation regulates cullin-based ubiquitination in tumorigenesis. Acta Pharm Sin B. 2021;11:309\u201321.","journal-title":"Acta Pharm Sin B"},{"key":"1064_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109270","volume":"27","author":"S Huang","year":"2024","unstructured":"Huang S, Zhang P, Yin N, Xu Z, Liu X, Wu A, et al. Glioblastoma stem cell-derived exosomal miR-374b-3p promotes tumor angiogenesis and progression through inducing M2 macrophages polarization. iScience. 2024;27:109270.","journal-title":"iScience"},{"key":"1064_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1275330","volume":"14","author":"JF Scarini","year":"2024","unstructured":"Scarini JF, Goncalves MWA, de Lima-Souza RA, Lavareze L, de Carvalho Kimura T, Yang CC, et al. Potential role of the Eph\/ephrin system in colorectal cancer: emerging druggable molecular targets. Front Oncol. 2024;14:1275330.","journal-title":"Front Oncol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01064-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01064-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01064-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:02:50Z","timestamp":1787774570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01064-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01064-1","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}